A Novel Glycine Receptor Variant with Startle Disease Affects Syndapin I and Glycinergic Inhibition

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • 4954.full

    Forlagets udgivne version, 3,27 MB, PDF-dokument

  • Georg Langlhofer
  • Natascha Schaefer
  • Hans M. Maric
  • Angelo Keramidas
  • Yan Zhang
  • Peter Baumann
  • Robert Blum
  • Ulrike Breitinger
  • Strømgaard, Kristian
  • Andreas Schlosser
  • Michael M. Kessels
  • Dennis Koch
  • Britta Qualmann
  • Hans Georg Breitinger
  • Joseph W. Lynch
  • Carmen Villmann

Glycine receptors (GlyRs) are the major mediators of fast synaptic inhibition in the adult human spinal cord and brainstem. Hereditary mutations to GlyRs can lead to the rare, but potentially fatal, neuromotor disorder hyperekplexia. Most mutations located in the large intracellular domain (TM3-4 loop) of the GlyRa1 impair surface expression levels of the receptors. The novel GLRA1 mutation P366L, located in the TM3-4 loop, showed normal surface expression but reduced chloride currents, and accelerated whole-cell desensitization observed in whole-cell recordings. At the single-channel level, we observed reduced unitary conductance accompanied by spontaneous opening events in the absence of extracellular glycine. Using peptide microarrays and tandem MS-based analysis methods, we show that the proline-rich stretch surrounding P366 mediates binding to syndapin I, an F-BAR domain protein involved in membrane remodeling. The disruption of the noncanonical Src homology 3 recognition motif by P366L reduces syndapin I binding. These data suggest that the GlyRa1 subunit interacts with intracellular binding partners and may therefore play a role in receptor trafficking or synaptic anchoring, a function thus far only ascribed to the GlyRb subunit. Hence, the P366L GlyRa1 variant exhibits a unique set of properties that cumulatively affect GlyR functionality and thus might explain the neuropathological mechanism underlying hyperekplexia in the mutant carriers. P366L is the first dominant GLRA1 mutation identified within the GlyRa1 TM3-4 loop that affects GlyR physiology without altering protein expression at the whole-cell and surface levels.

OriginalsprogEngelsk
TidsskriftJournal of Neuroscience
Vol/bind40
Udgave nummer25
Sider (fra-til)4954-4969
Antal sider16
ISSN0270-6474
DOI
StatusUdgivet - 2020

Bibliografisk note

Funding Information:
This work was supported by Deutsche Forschungsgemeinschaft Grants VI586 (C.V.), QU116/5, and DFG CRC166 (B.Q.). J.W.L. is supported by National Health and Medical Research Council Grant 1058542. G.L. was supported by the Graduate School of Life Sciences Würzburg as well as the Bayerische Forschungsstiftung. We thank Cord-Michael Becker for the assignment of blood samples from patients for research purposes. We also thank Nadine Vornberger for excellent technical assistance.

Publisher Copyright:
Copyright © 2020 the authors

Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk


Ingen data tilgængelig

ID: 271634094